Literature DB >> 9503495

[Epidemiology of severe chronic renal insufficiency in Burkina Faso].

A Lengani1, G Coulibaly, M Laville, P Zech.   

Abstract

We identified 174 cases of chronic severe renal failure (blood creatinine > 650 mumol/l) and/or blood urea > 35 mmol/l) in a retrospective study of patients admitted to hospital between January 1989 and June 1996. Of these patients, 110 were men and 64 were women. The mean age was 36 +/- 15 years. Fifty three patients had a history of hypertension before admission, 3 patients had diabetes and 3 had gout. The most frequent clinical signs were dyspnea (55.2% of all patients), fatigue (78.2%), vomiting (63.2%) and edema (66.1%). The prevalence of hypertension was 64.9%. Glomerulonephritis was found in 42.5% of patients, chronic interstitial nephritis in 16.1%, polycystic kidney disease in 2 cases, congenital renal hypoplasia in 4 cases and unclassified kidney disease in 14.4% of cases. End-stage renal failure was complicated by heart failure in 40.2% of patients, pericarditis in 31.6%, hemorrhage of the gastrointestinal tract in 15% and infections in 22.4%. 47.7% of the patients died following admission.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9503495

Source DB:  PubMed          Journal:  Sante        ISSN: 1157-5999


  3 in total

1.  Prevalence of CKD-MBD in pre-dialysis patients using biochemical markers in Enugu, South-East Nigeria.

Authors:  Julius U Okoye; Ejikeme B Arodiwe; Ifeoma I Ulasi; Chinwuba K Ijoma; Obinna D Onodugo
Journal:  Afr Health Sci       Date:  2015-09       Impact factor: 0.927

2.  Epidemiology of Histologically Proven Glomerulonephritis in Africa: A Systematic Review and Meta-Analysis.

Authors:  Ikechi G Okpechi; Oluwatoyin I Ameh; Aminu K Bello; Pierre Ronco; Charles R Swanepoel; Andre P Kengne
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

Review 3.  Prevalence and burden of chronic kidney disease among the general population and high-risk groups in Africa: a systematic review.

Authors:  Samar Abd ElHafeez; Davide Bolignano; Graziella D'Arrigo; Evangelia Dounousi; Giovanni Tripepi; Carmine Zoccali
Journal:  BMJ Open       Date:  2018-01-10       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.